Abstracts Archive - Page 1957 of 2425 - ACR Meeting Abstracts

Abstract Number: 1432 • 2014 ACR/ARHP Annual Meeting
Mortality Ratio of Rheumatoid Arthritis Under Biological Treatment
Umut Kalyoncu¹, Abdulsamet Erden², Hakan Babaoglu³, Murat Torgutalp³, Sadettin Kilickap⁴, Omer Karadag⁵, Sule Apras Bilgen⁵, Ihsan Ertenli¹, Ali Akdogan⁵ and Sedat Kiraz⁵, ¹Rheumatology, Hacettepe University School of Medicine, Ankara, Turkey, ²Rheumatology,Hacettepe University Faculty of Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey, ³Internal Medicine, Hacettepe University, Faculty of Medicine, Ankara, Turkey, ⁴Preventive Oncology, Hacettepe University, Faculty of Medicine, Ankara, Turkey, ⁵Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey
Mortality Ratio of Rheumatoid Arthritis Under Biological Treatment: HUR-BIO real life results.Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory disease, which, in many patients, leads…
Abstract Number: 1431 • 2014 ACR/ARHP Annual Meeting
Influence of Radiographic Joint Damage in Mortality Risk in a Cohort of Rheumatoid Arthritis Patients: A 20 Years Survival Study
L. Rodriguez-Rodriguez^1,2, J. Ivorra-Cortes³, Lydia Abasolo^1,4, Leticia Leon^1,4, Oscar Fontsere⁵, B. Fernández-Gutiérrez^1,5 and Juan A Jover^1,4, ¹Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain, ²Department of Rheumatology, Hospital Clínico San Carlos, Madrid, Spain, ³Rheumatology, University Hospital la Fe, Valencia, Spain, ⁴Rheumatology, Hospital Clinico San Carlos, Madrid, Spain, ⁵Rheumatology, Hospital Clínico San Carlos, Madrid, Spain
Background/Purpose Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with increased mortality and reduced life expectancy compared with the general population. This mortality gap…
Abstract Number: 1430 • 2014 ACR/ARHP Annual Meeting
IMPACT of Initiative to Control Cardiovascular Risk Factors in Collaboration with LOCAL Doctors in Patients with Rheumatoid Arthritis
Andrea Zacarias Crovato¹, Javier Narváez², Joan Miquel Nolla³, Jesús Rodríguez-Moreno⁴, Montserrat Jordana¹ and Carmen Gomez Vaquero³, ¹Hospital Universitari de Bellvitge, Barcelona, Spain, ²Rheumatology, Hospital Universitario de Bellvitge. Barcelona. Spain, Barcelona, Spain, ³Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, ⁴Rheumatology, Hospital Universitari de Bellvitge, Barcelona, Spain
Background/Purpose: Rheumatoid arthritis (RA) is associated with cardiovascular risk (CVR) with an increased prevalence of cardiovascular events and cardiovascular mortality than the general population. Good…
Abstract Number: 1421 • 2014 ACR/ARHP Annual Meeting
Preclinical Interstitial Lung Disease in Early Rheumatoid Arthritis
Javier Narváez¹, Alejandro Robles Perez², Maria Molina Molina³ and Joan Miquel Nolla⁴, ¹Rheumatology, Hospital Universitario de Bellvitge. Barcelona. Spain, Barcelona, Spain, ²Pneumology, Hospital Universitario de Bellvitge, Barcelona, Spain, ³Hospital Universitario de Bellvitge, Barcelona, Spain, ⁴Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain
Background/Purpose: Early detection and treatment of interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA) may ameliorate disease progression. The objective of the present…
Abstract Number: 1420 • 2014 ACR/ARHP Annual Meeting
Non-Use of Glucocorticoid and Osteoarthritis Absence As Predictors of Clinical Remission in AR
Salvador Loredo-Alanís¹, David Vega-Morales², Mario Garza-Elizondo¹, Mario Garcia-Pompermayer³, Roberto Negrete-López¹, Daniel Treviño-Montes¹ and Diana Flores-Alvarado², ¹Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Mexico, ²Rheumatology, Hospital Universitario UANL, Monterrey, Mexico, ³Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterey, Mexico
Background/Purpose The clinical evaluation of Rheumatoid arthritis (RA) is accomplished with compound indexes allowing better clinical decision. Clinical remission nowadays is an attainable target in…
Abstract Number: 1419 • 2014 ACR/ARHP Annual Meeting
Rituximab Use in Patients with Rheumatoid Arthritis-Associated Interstitial Lung Disease and Other Connective Tissue Disease-Associated Interstitial Lung Disease: A Single Center Experience
Sandra Chartrand^1,2, Jeffery J. Swigris³, Lina Peykova² and Aryeh Fischer⁴, ¹Rheumatology, Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada, ²Rheumatology, National Jewish Health, Denver, CO, ³Autoimmune Lung Center, National Jewish Health, Denver, CO, ⁴Rheumatology / ILD Program, National Jewish Health, Denver, CO
Background/Purpose: Small series have suggested that rituximab (RTX) may be effective as rescue-therapy for connective tissue disease-associated interstitial lung disease (CTD-ILD). We sought to describe…
Abstract Number: 1418 • 2014 ACR/ARHP Annual Meeting
Prevalence of Vitamin D Deficiency in Rheumatoid Arthritis
Stella Cecchetti¹, Martin Soubrier², Pilar Galan^3,4, Bruno Pereira⁵, Gael Mouterde⁶ and Maxime Dougados⁷, ¹Rheumatology department, CHU Gabriel Montpied, 63000, France, ²Rheumatology, CHU G.-Montpied, Clermont-Ferrand, France, ³Nutritional Epidemiology Research Unit, INSERM (U1153), Bobigny, France, ⁴Université Paris 13, Sorbonne Paris Cité, Paris Cité, France, ⁵Clinical research department, Clermont-Ferrand, France, ⁶Immunologie Rhumatologie, Hopital Lapeyronie, Montpellier, France, ⁷RAID working group for EULAR, Zurich, Switzerland
Background/Purpose Serum levels of vitamin D (VitD) are usually inversely correlated with RA activity. However, the prevalence of VitD deficiency does not appear to differ…
Abstract Number: 1417 • 2014 ACR/ARHP Annual Meeting
Red Cell Distribution Width: A Measure for Cardiovascular Risk in Rheumatoid Arthritis Patients?
Sobia Hassan¹, Maria Antonelli² and Stanley P Ballou³, ¹Rheumatology, Case Western Reserve University, MetroHealth Medical Center, Cleveland, OH, ²Rheumatology, Case Western Reserve University School of Medicine at MetroHealth Medical Center, Cleveland, OH, ³Division of Rheumatology, MetroHealth Medical Center / Case Western Reserve University, Cleveland, OH
Background/Purpose: Red cell distribution width (RDW) is a measure of the variation in red blood cell size reported on the automated complete blood count. Although…
Abstract Number: 1416 • 2014 ACR/ARHP Annual Meeting
Analysis of Cardiac Involvement in Patients with Amyloid a (AA) Amyloidosis Due to Rheumatoidarthritis
Daisuke Kobayashi¹, Satoshi Ito¹, Satoru Kodama¹, Akira Murasawa¹, Ichiei Narita² and Kiyoshi Nakazono¹, ¹Niigata Rheumatic Center, Shibata, Japan, ²Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
Background/Purpose Rheumatoid arthritis (RA) is one of the major causes of amyloid A (AA) amyloidosis. The major organs affected are the kidneys and gastrointestinal (GI)…
Abstract Number: 1415 • 2014 ACR/ARHP Annual Meeting
Differential Gender Impact in the Quality of Life of Patients with Rheumatoid Arthritis. Comprehensive Study Including Clinical, Comorbidity and Psicho-Social Variables.
Elena Aurrecoechea¹, Jaime Calvo-Alen², Graciela S. Alarcon³, Gerald McGwin Jr.⁴, Maria Luisa Diez Lizuain⁵ and Javier Llorca⁶, ¹Hospital Sierrallana. Torrelavega, Torrelavega, Spain, ²Rheumatology, Hospital de Sierrallana. Torrelavega. Spain, Torrelavega, Spain, ³Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, ⁴Rheumatologist, Birmingham, AL, ⁵MD, Torrelavega, Spain, ⁶Department of Epidemiology and Computational Biology, School of Medicine, University of Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP), IDIVAL, Santander, Spain
Background/Purpose: To evaluate whether gender portends a differential impact in the outcome of RA in terms of quality of life (QOL) and which type of…
Abstract Number: 1414 • 2014 ACR/ARHP Annual Meeting
Investigation of the Association Between Gastroesophageal Reflux Disease and Clinical Factors in Patients with Rheumatoid Arthritis
Katsushi Ishii¹, Yuichi Mochida¹, Yuki Ozawa¹, Naoto Mitsugi² and Tomoyuki Saito³, ¹Center for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama, Japan, ²Orthopaedic Surgery, Yokohama City University Medical Center, Yokohama, Japan, ³Orthopaedic Surgery, Yokohama City University School of Medicine, Yokohama, Japan
Background/Purpose: Gastroesophageal reflux disease (GERD) is caused by the abnormal reflux of the gastric contents into the esophagus. Many risk factors are considered as a…
Abstract Number: 1413 • 2014 ACR/ARHP Annual Meeting
The Prevalence of Renal Impairment in Patients with Rheumatoid Arthritis
Marion Couderc Sr.¹, Martin Soubrier², Bruno Pereira³, Aurelien Tiple⁴, Melanie Gilson⁵, Bruno Fautrel⁶, Sophie Pouplin⁷, Emmanuelle Dernis Labous⁸, Laure Gossec⁹, Cécile Gaujoux-Viala¹⁰ and Maxime Dougados¹¹, ¹Chu G.Montpied, Clermont Ferrand, France, ²Rheumatology, CHU G.-Montpied, Clermont-Ferrand, France, ³Clinical research department, Clermont-Ferrand, France, ⁴Nephrology, CHU, Clermont-Ferrand, France, ⁵Rheumatology, CHu Grenoble, Grenoble, France, ⁶Rheumatology, Pitie Salpetriere Hospital, Paris, France, ⁷Rheumatology, Rouen University Hospital, Rouen, France, ⁸Rhumatologie, Ch Du Mans, Le Mans, France, ⁹Rheumatology, UPMC GRC08, Paris 06 University, Pitié Salpétrière Hospital, Paris, France, ¹⁰EA 2415, Montpellier I University, Nîmes University Hospital, Rheumatology Department, Nîmes, France, ¹¹Université Paris René Descartes and Hôpital Cochin, Paris, France
Background/Purpose: To assess the prevalence and associations of renal dysfunction in patients with rheumatoid arthritis (RA). Methods: COMEDRA is a French nationwide cross-sectional multicentre study…
Abstract Number: 1412 • 2014 ACR/ARHP Annual Meeting
Sarcopenia and Its Impact on Disability in Rheumatoid Arthritis, a Pilot Study
Meltem Alkan Melikoglu¹ and Kazim Senel², ¹Rheumatology, Ataturk University Faculty of Medicine, Erzurum, Turkey, ²Physical Medicine and Rehabilitation, Ataturk University Medical School, Erzurum, Turkey
Background/Purpose: Rheumatoid arthritis (RA) is associated with increased morbidity and mortality due to several metabolic deteriorations one of which is sarcopenia. The aim of this…
Abstract Number: 1411 • 2014 ACR/ARHP Annual Meeting
Psychological Distress over Time in Early Rheumatoid Arthritis: Results from a Longitudinal Study in an Early Arthritis Cohort
Bernard Combe¹, Nathalie Rincheval², René-Marc Flipo³, Philipe M. Goupille⁴, Jean-Pierre Daurès² and JP Boulenger⁵, ¹Immuno-Rhumatologie, Hôpital Lapeyronie, Montpellier, France, ²Institut Universitaire de Recherche Clinique, Montpellier, France, ³Rheumatology, Hopital R Salengro CHRU, Lille CEDEX, France, ⁴Rheumatology, Hopital Trousseau, Tours, France, ⁵CHRU Montpellier I University, La Colombiere Hospital, Montpellier, France
Background/Purpose Rheumatoid arthritis (RA) is a chronic disease with frequent psychological comorbidities, of which depression and anxiety are 2 common manifestations. We aimed to identify…
Abstract Number: 1410 • 2014 ACR/ARHP Annual Meeting
Low Rates of Cardiovascular Risk Factor Modification Among High-Risk Rheumatoid Arthritis Patients: Barrier to Cardiovascular Prevention Strategies?
Kimberly P. Liang¹, Rohit Aggarwal², Juan (June) Feng³, Jason Lyons³, Heather Eng³, Stephen R. Wisniewski³, Melissa Saul⁴, Douglas P. Landsittel⁵, Douglas W. Chew¹, Aryan Aiyer⁶ and Larry W. Moreland⁷, ¹Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, ²Medicine, University of Pittsburgh, Pittsburgh, PA, ³Epidemiology Data Center, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, ⁴Biomedical Informatics, University of Pittsburgh, School of Medicine, Pittsburgh, PA, ⁵Medicine, Biostatistics and Clinical and Translational Science, University of Pittsburgh, Center for Health Care Research Data Center, Pittsburgh, PA, ⁶Department of Medicine, Division of Cardiology, University of Pittsburgh Medical Center, Pittsburgh, PA, ⁷Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA
Background/Purpose: Despite higher risk of cardiovascular disease (CVD) in rheumatoid arthritis (RA), systematic cardiovascular (CV) prevention strategies are lacking. Recent guidelines for CV risk…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].